# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001641172-25-004594
Filing Date
2025-04-14
Accepted
2025-04-14 17:05:17
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formars.pdf | ARS | 1007746
| Complete submission text file | 0001641172-25-004594.txt |  | 1389593

Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-11460 | Film No.: 25836664
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)